Key result
Growth hormone therapy in children with idiopathic GH deficiency faces unresolved diagnostic challenges, including poor reproducibility of stimulation tests and arbitrary threshold definitions.
Why the study?
Major clinical problems regarding arbitrary diagnostic thresholds, test inaccuracy, and optimal duration of GH therapy in children with isolated GHD have remained unresolved for decades.
Population
Children and adolescents with idiopathic growth hormone deficiency (GHD)
Design
Review
Authors
Loading...
Diagnostic inconsistencies in idiopathic GH deficiency warrant cautious therapy decisions; leaves open standardization of stimulation thresholds.
This review highlights the need to resolve long-standing diagnostic and therapeutic challenges in managing children with idiopathic growth hormone deficiency to optimize their care.
Joanna Smyczyńska (2022) conducted a review in Idiopathic Growth Hormone Deficiency. Growth Hormone (GH) Therapy was evaluated. Growth hormone therapy in children with idiopathic GH deficiency faces unresolved diagnostic challenges, including poor reproducibility of stimulation tests and arbitrary threshold definitions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: